These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

343 related items for PubMed ID: 15938664

  • 1. Transdermal buprenorphine in the treatment of chronic pain.
    Sittl R.
    Expert Rev Neurother; 2005 May; 5(3):315-23. PubMed ID: 15938664
    [Abstract] [Full Text] [Related]

  • 2. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J, Böger RH, Budd K, Dahan A, Erdine S, Hans G, Kress HG, Langford R, Likar R, Raffa RB, Sacerdote P.
    Pain Pract; 2008 May; 8(4):287-313. PubMed ID: 18503626
    [Abstract] [Full Text] [Related]

  • 3. Long-term management of chronic pain with transdermal buprenorphine: a multicenter, open-label, follow-up study in patients from three short-term clinical trials.
    Likar R, Kayser H, Sittl R.
    Clin Ther; 2006 Jun; 28(6):943-52. PubMed ID: 16860176
    [Abstract] [Full Text] [Related]

  • 4. Transdermal buprenorphine patches applied in a 4-day regimen versus a 3-day regimen: a single-site, Phase III, randomized, open-label, crossover comparison.
    Likar R, Lorenz V, Korak-Leiter M, Kager I, Sittl R.
    Clin Ther; 2007 Aug; 29(8):1591-606. PubMed ID: 17919542
    [Abstract] [Full Text] [Related]

  • 5. Transdermal buprenorphine in the treatment of chronic pain: results of a phase III, multicenter, randomized, double-blind, placebo-controlled study.
    Sorge J, Sittl R.
    Clin Ther; 2004 Nov; 26(11):1808-20. PubMed ID: 15639693
    [Abstract] [Full Text] [Related]

  • 6. Transdermal buprenorphine in clinical practice--a post-marketing surveillance study in 13,179 patients.
    Griessinger N, Sittl R, Likar R.
    Curr Med Res Opin; 2005 Aug; 21(8):1147-56. PubMed ID: 16083522
    [Abstract] [Full Text] [Related]

  • 7. Effectiveness and tolerability of the buprenorphine transdermal system in patients with moderate to severe chronic pain: a multicenter, open-label, uncontrolled, prospective, observational clinical study.
    Muriel C, Failde I, Micó JA, Neira M, Sánchez-Magro I.
    Clin Ther; 2005 Apr; 27(4):451-62. PubMed ID: 15922818
    [Abstract] [Full Text] [Related]

  • 8. Opioid rotation from high-dose morphine to transdermal buprenorphine (Transtec) in chronic pain patients.
    Freye E, Anderson-Hillemacher A, Ritzdorf I, Levy JV.
    Pain Pract; 2007 Jun; 7(2):123-9. PubMed ID: 17559481
    [Abstract] [Full Text] [Related]

  • 9. Buprenorphine TDS: the clinical development rationale and results.
    Radbruch L, Vielvoye-Kerkmeer A.
    Int J Clin Pract Suppl; 2003 Feb; (133):15-8; discussion 23-4. PubMed ID: 12665119
    [Abstract] [Full Text] [Related]

  • 10. The role of transdermal buprenorphine in the treatment of cancer pain: an expert panel consensus.
    Pergolizzi JV, Mercadante S, Echaburu AV, Van den Eynden B, Fragoso RM, Mordarski S, Lybaert W, Beniak J, Orońska A, Slama O, Euromed Communications meeting.
    Curr Med Res Opin; 2009 Jun; 25(6):1517-28. PubMed ID: 19435402
    [Abstract] [Full Text] [Related]

  • 11. Transdermal buprenorphine in cancer pain and palliative care.
    Sittl R.
    Palliat Med; 2006 Jun; 20 Suppl 1():s25-30. PubMed ID: 16764218
    [Abstract] [Full Text] [Related]

  • 12. [Post marketing surveillance study with an analgesic (transdermal buprenorphine patch) in patients with moderate to severe chronic pain].
    Tschirner M, Ritzdorf I, Brünjes R.
    MMW Fortschr Med; 2008 Sep 18; 150 Suppl 3():142-8. PubMed ID: 19025217
    [Abstract] [Full Text] [Related]

  • 13. Transdermal buprenorphine in pain management--experiences from clinical practice: Five case studies.
    Louis F.
    Int J Clin Pract; 2006 Oct 18; 60(10):1330-4. PubMed ID: 16981980
    [Abstract] [Full Text] [Related]

  • 14. Transdermal buprenorphine in chronic pain: indications and clinical experience.
    Kusnik S, Likar R, Sittl R.
    Expert Rev Clin Pharmacol; 2008 Nov 18; 1(6):729-36. PubMed ID: 24410602
    [Abstract] [Full Text] [Related]

  • 15. A feasibility study of transdermal buprenorphine versus transdermal fentanyl in the long-term management of persistent non-cancer pain.
    Mitra F, Chowdhury S, Shelley M, Williams G.
    Pain Med; 2013 Jan 18; 14(1):75-83. PubMed ID: 23320402
    [Abstract] [Full Text] [Related]

  • 16. [The transdermal 7-day buprenorphine patch--an effective and safe treatment option, if tramadol or tilidate/naloxone is insufficient. Results of a non-interventional study].
    Schutter U, Ritzdorf I, Heckes B.
    MMW Fortschr Med; 2010 Jul 01; 152 Suppl 2():62-9. PubMed ID: 21591321
    [Abstract] [Full Text] [Related]

  • 17. Buprenorphine transdermal delivery system in adults with persistent noncancer-related pain syndromes who require opioid therapy: a multicenter, 5-week run-in and randomized, double-blind maintenance-of-analgesia study.
    Landau CJ, Carr WD, Razzetti AJ, Sessler NE, Munera C, Ripa SR.
    Clin Ther; 2007 Oct 01; 29(10):2179-93. PubMed ID: 18042474
    [Abstract] [Full Text] [Related]

  • 18. Clinical update on the pharmacology, efficacy and safety of transdermal buprenorphine.
    Kress HG.
    Eur J Pain; 2009 Mar 01; 13(3):219-30. PubMed ID: 18567516
    [Abstract] [Full Text] [Related]

  • 19. High dose transdermal buprenorphine for moderate to severe pain in spanish pain centres--a retrospective multicenter safety and efficacy study.
    Barutell C, Camba A, González-Escalada JR, Rodríguez M, Opioid Group of the Spanish Society for the Study of Pain.
    Pain Pract; 2008 Mar 01; 8(5):355-61. PubMed ID: 18662364
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and safety of transdermal buprenorphine: a randomized, placebo-controlled trial in 289 patients with severe cancer pain.
    Poulain P, Denier W, Douma J, Hoerauf K, Samija M, Sopata M, Wolfram G.
    J Pain Symptom Manage; 2008 Aug 01; 36(2):117-25. PubMed ID: 18411010
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.